The Drug Regulatory Authority of Pakistan (DRAP) has granted ‘emergency use approval’ to the CanSinoBIO Recombinant Covid-19 Vaccine Adenovirus Type 5 Vector (the “Ad5-nCoV”) and its marketing through private and public sector. According to an official of DRAP, the approval has been granted following the communication of the results of the interim analysis of the […]
from Daily Times https://ift.tt/2Zo6aiA
Subscribe to:
Post Comments (Atom)
-
from Pakistani Talk Shows, Latest Pakistan News, Urdu News, Breaking News Pakistan http://bit.ly/2SE0NXv
-
Dailymotion from Pakistani Talk Shows, Latest Pakistan News, Urdu News, Breaking News Pakistan https://ift.tt/2SsPZe5
-
In Haiti, virus crisis leaves cancer patients in limbo In early March, 31-year-old Melchior visited a doctor in his home country of Haiti, ...
No comments:
Post a Comment